Edwards Lifesciences (EW) vs GE HealthCare Technologies (GEHC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Edwards Lifesciences (EW) has outperformed GE HealthCare Technologies (GEHC) over the past year, gaining 11.8% versus a loss of 13.2%. Edwards Lifesciences is the larger company by market cap ($47.73 billion vs $28.72 billion), about 1.7 times the size. On valuation, GE HealthCare Technologies trades at a lower forward P/E (11.8x vs 24.5x for Edwards Lifesciences).
GE HealthCare Technologies pays a dividend yielding 0.22%, while Edwards Lifesciences does not currently pay one. Edwards Lifesciences converts more of its revenue into profit, with a net margin of 17.7% versus 10.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EW | GEHC |
|---|---|---|
| Share price | $82.81 | $63.58 |
| Market cap | $47.73B | $28.72B |
| 1-day change | -3.47% | -1.69% |
| YTD return | +0.62% | -21.15% |
| 1-year return | +11.81% | -13.18% |
| 5-year return | -23.52% | — |
| P/E ratio (TTM) | 49.29 | 14.62 |
| Forward P/E | 24.47 | 11.75 |
| EPS (TTM) | $1.68 | $4.35 |
| Dividend yield | 0.00% | 0.22% |
| Annual dividend | $0.00 | $0.14 |
| Revenue (latest FY) | $6.07B | $20.63B |
| Revenue growth (YoY) | +11.55% | +4.84% |
| Net income (latest FY) | $1.07B | $2.08B |
| Gross margin | 78.01% | 39.99% |
| Operating margin | 20.84% | 13.40% |
| Net margin | 17.69% | 10.10% |
| 52-week high | $96.29 | $89.77 |
| 52-week low | $72.30 | $58.75 |
| Distance from 52-week high | -14.00% | -29.17% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +23.13% | +30.39% |
| Average volume | 3.82M | 4.08M |
| Shares outstanding | 576.40M | 451.69M |
| Employees | 16,000 | 54,000 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Medical Electronics |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EW has outperformed GEHC by 25.0 percentage points over the past year.
- Edwards Lifesciences trades at a higher earnings multiple (49.3x vs 14.6x trailing P/E).
- Edwards Lifesciences is more profitable, keeping 17.7 cents of every revenue dollar as net income versus 10.1 cents for GE HealthCare Technologies.
- Edwards Lifesciences grew revenue faster in its latest fiscal year (+11.55% vs +4.84%).
About Edwards Lifesciences
EW stock →Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands.
Health Care · Industrial Specialties · 16,000 employees
About GE HealthCare Technologies
GEHC stock →GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally.
Health Care · Medical Electronics · 54,000 employees
EW vs GEHC FAQ
Which is bigger, Edwards Lifesciences or GE HealthCare Technologies?
Edwards Lifesciences (EW) is larger, with a market capitalization of $47.73B compared with $28.72B for GE HealthCare Technologies (GEHC).
Which stock has performed better over the past year, EW or GEHC?
EW returned +11.81% over the past 12 months, compared with -13.18% for GEHC (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, EW or GEHC?
GEHC has the lower trailing P/E at 14.6, versus 49.3 for EW. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Edwards Lifesciences or GE HealthCare Technologies?
GE HealthCare Technologies pays a dividend yielding 0.22%, while Edwards Lifesciences does not currently pay a regular dividend.
Are Edwards Lifesciences and GE HealthCare Technologies in the same industry?
Both are in the Health Care sector, but in different industries: Industrial Specialties for Edwards Lifesciences and Medical Electronics for GE HealthCare Technologies.